P72 Efficacy and Safety of Mirikizumab As Maintenance Therapy in Patients with Moderate-Severe Active Ulcerative Colitis: Phase 3 LUCENT-2 Study Results

Poster presentations(2023)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要